original evaluation c-a 2008 · pdf fileoriginal evaluation c-a 2008 chemistry institution:...
TRANSCRIPT
EVALUATIONORIGINAL
C-A 2008 Chemistry
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:4/11/20083/3/2008Original Evaluation:
Kit#7181660-01 1
Kit Mailed:20617630 Kit ID:
Claudia Velasquez MT
Next Mailing Date:6/2/2008
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:[11] = Unable to analyze (documentation to be provided by laboratory).[20] = No appropriate target/response cannot be graded.[26] = Educational challenge.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 20
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 169 161.8 4.4 216 +1.6 129 195 AcceptableCHM-02 187 177.6 4.6 214 +2.0 142 214 AcceptableCHM-03 135 128.6 3.7 216 +1.7 102 155 AcceptableCHM-04 102 96.8 2.9 216 +1.8 77 117 AcceptableCHM-05 70 65.2 2.3 215 +2.1 52 79 Acceptable
TestUnit of Measure
Peer Group
ALT (SGPT)U/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2008C-C 2007
C-B 2007
CHM-01 4.6 4.61 0.08 104 -0.2 4.1 5.1 AcceptableCHM-02 4.8 4.81 0.07 103 -0.1 4.3 5.3 AcceptableCHM-03 4.3 4.25 0.09 108 +0.6 3.8 4.7 AcceptableCHM-04 3.9 3.87 0.09 108 +0.4 3.4 4.3 AcceptableCHM-05 3.5 3.49 0.08 105 +0.1 3.1 3.9 Acceptable
Albuming/dL
ABBOTT ARCH C/AEROSETDYE BINDING-BCG
C-A 2008C-C 2007
C-B 2007
CHM-01 303 342.6 4.8 209 -8.3 239 446 AcceptableCHM-02 334 377.1 5.2 209 -8.2 263 491 AcceptableCHM-03 242 274.3 4.1 210 -7.8 191 357 AcceptableCHM-04 183 206.1 3.3 213 -7.0 144 268 AcceptableCHM-05 123 138.3 2.5 214 -6.2 96 180 Acceptable
Alkaline PhosphataseU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
C-A 2008C-C 2007
C-B 2007
CHM-01 318 294.3 6.1 203 +3.9 205 383 AcceptableCHM-02 348 323.7 6.4 203 +3.8 226 421 AcceptableCHM-03 256 237.2 4.7 201 +4.0 166 309 AcceptableCHM-04 196 181.7 3.7 201 +3.8 127 237 AcceptableCHM-05 137 126.7 2.6 202 +3.9 88 165 Acceptable
Amylase, serumU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
C-A 2008C-C 2007
C-B 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 201 201.6 4.9 217 -0.1 161 242 AcceptableCHM-02 220 220.1 5.2 217 0.0 176 265 AcceptableCHM-03 164 165.3 3.8 217 -0.3 132 199 AcceptableCHM-04 129 128.7 3.1 217 +0.1 102 155 AcceptableCHM-05 93 92.4 2.2 217 +0.3 73 111 Acceptable
TestUnit of Measure
Peer Group
AST (SGOT)U/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2008C-C 2007
C-B 2007
CHM-01 2.9 3.04 0.29 15 -0.5 2.4 3.7 AcceptableCHM-02 3.2 3.28 0.35 15 -0.2 2.6 4.0 AcceptableCHM-03 2.5 2.54 0.25 15 -0.2 2.0 3.1 AcceptableCHM-04 1.9 1.94 0.19 15 -0.2 1.5 2.4 AcceptableCHM-05 1.3 1.32 0.11 15 -0.2 0.9 1.8 Acceptable
Bilirubin, directmg/dL
ABBOTT ARCH C/AEROSETOXIDATION
C-A 2008C-C 2007
C-B 2007
CHM-01 7.2 6.21 0.25 22 +4.0 4.9 7.5 AcceptableCHM-02 8.0 6.77 0.33 22 +3.7 5.4 8.2 AcceptableCHM-03 5.8 5.04 0.37 24 +2.1 4.0 6.1 AcceptableCHM-04 4.4 3.74 0.29 24 +2.2 2.9 4.5 AcceptableCHM-05 2.9 2.46 0.10 22 +4.2 1.9 3.0 Acceptable
Bilirubin, totalmg/dL
ABBOTT ARCH C/AEROSETOXIDATION
C-A 2008C-C 2007
C-B 2007
CHM-01 12.3 12.48 0.15 217 -1.2 11.4 13.5 AcceptableCHM-02 13.1 13.22 0.17 218 -0.7 12.2 14.3 AcceptableCHM-03 10.9 10.98 0.15 219 -0.5 9.9 12.0 AcceptableCHM-04 9.3 9.43 0.14 221 -1.0 8.4 10.5 AcceptableCHM-05 8.0 8.00 0.12 220 0.0 6.9 9.0 Acceptable
Calcium, serummg/dL
ABBOTT ARCH C/AEROSETARSENAZO III DYE
C-A 2008C-C 2007
C-B 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 116 115.3 1.4 219 +0.5 109 122 AcceptableCHM-02 119 119.5 1.3 218 -0.3 113 126 AcceptableCHM-03 106 107.3 1.4 219 -1.0 101 113 AcceptableCHM-04 100 99.4 1.3 221 +0.5 94 105 AcceptableCHM-05 92 91.4 1.3 221 +0.4 86 97 Acceptable
TestUnit of Measure
Peer Group
Chloridemmol/L
ABBOTT ARCH C/AEROSETION SELECT ELECT DIL
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2008C-C 2007
C-B 2007
CHM-01 257 257.5 2.8 211 -0.2 231 284 AcceptableCHM-02 272 274.6 3.1 213 -0.8 247 303 AcceptableCHM-03 222 224.2 2.4 213 -0.9 201 247 AcceptableCHM-04 191 191.0 2.0 211 0.0 171 211 AcceptableCHM-05 158 158.5 1.7 210 -0.3 142 175 Acceptable
Cholesterolmg/dL
ABBOTT ARCH C/AEROSETENZYMATIC
C-A 2008C-C 2007
C-B 2007
CHM-01 30.8 32.05 2.25 37 -0.6 24.0 40.1 AcceptableCHM-02 34.0 35.34 2.65 37 -0.5 26.5 44.2 AcceptableCHM-03 23.8 26.14 1.86 37 -1.3 19.6 32.7 AcceptableCHM-04 21.5 20.39 1.44 37 +0.8 15.2 25.5 AcceptableCHM-05 16.8 15.24 0.89 37 +1.8 11.4 19.1 Acceptable
Cortisol, serumug/dL
ABBOTT AXSYMC-A 2008C-C 2007
C-B 2007
CHM-01 760 1 [20]CHM-02 821 1 [20]CHM-03 594 1 [20]CHM-04 465 1 [20]CHM-05 330 1 [20]
Creatine KinaseU/L
OTHER REAGENT/TEMPABBOTT ARCH C/AEROSET
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 4 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 7CHM-02 7CHM-03 7CHM-04 7CHM-05 7CHM-01 6.10 6.129 0.276 126 -0.1 5.20 7.05 AcceptableCHM-02 6.70 6.710 0.338 127 0.0 5.70 7.72 AcceptableCHM-03 4.90 4.981 0.214 129 -0.4 4.23 5.73 AcceptableCHM-04 3.73 3.819 0.143 127 -0.6 3.24 4.40 AcceptableCHM-05 2.59 2.628 0.108 129 -0.3 2.23 3.03 Acceptable
TestUnit of Measure
Peer Group
Creatinine, serummg/dL
ALK PICRATE w/o LLOYDSABBOTT ARCH C/AEROSET
TRADITIONAL CALIBRATIO
Cal Method Mean
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2008C-C 2007
C-B 2007
CHM-01 341 345.7 6.0 211 -0.8 311 381 AcceptableCHM-02 373 379.0 6.3 215 -0.9 341 417 AcceptableCHM-03 278 279.5 4.8 214 -0.3 251 308 AcceptableCHM-04 212 216.0 3.8 215 -1.0 194 238 AcceptableCHM-05 149 153.5 2.6 214 -1.8 138 169 Acceptable
Glucose, serummg/dL
ABBOTT ARCH C/AEROSETHEXOKINASE, UV
C-A 2008C-C 2007
C-B 2007
CHM-01 102 98.0 3.3 164 +1.2 68 128 AcceptableCHM-02 109 105.5 3.6 164 +1.0 73 138 AcceptableCHM-03 88 83.3 2.9 165 +1.6 58 109 AcceptableCHM-04 72 68.9 2.7 166 +1.2 48 90 AcceptableCHM-05 59 54.9 2.5 166 +1.6 38 72 Acceptable
HDL Cholesterolmg/dL
ABBOTT ARCH C/AEROSETABBOTT ULTRA HDL
C-A 2008C-C 2007
C-B 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 5 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01CHM-02CHM-03CHM-04CHM-05CHM-01 859.4 807.99 33.55 112 +1.5 707.3 908.7 AcceptableCHM-02 946.6 875.01 34.12 111 +2.1 772.6 977.4 AcceptableCHM-03 652.2 615.08 25.33 109 +1.5 539.0 691.1 AcceptableCHM-04 485.5 442.57 18.58 112 +2.3 386.8 498.4 AcceptableCHM-05 266.2 271.10 13.50 112 -0.4 230.5 311.7 Acceptable
TestUnit of Measure
Peer Group
hCG, serum, quantmIU/mL
ABBOTT ARCHITECT i
Method
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2008C-C 2007
C-B 2007
CHM-01 210 208.7 5.7 13 +0.2 166 251 AcceptableCHM-02 223 224.7 5.9 13 -0.3 179 270 AcceptableCHM-03 176 179.2 5.6 13 -0.6 143 216 AcceptableCHM-04 146 148.5 5.6 13 -0.4 118 179 AcceptableCHM-05 114 117.5 4.9 13 -0.7 93 141 Acceptable
Ironug/dL
ABBOTT ARCH C/AEROSETFERENE w/PPR
C-A 2008C-C 2007
C-B 2007
CHM-01 358 347.8 7.1 202 +1.4 278 418 AcceptableCHM-02 381 375.0 7.7 202 +0.8 300 451 AcceptableCHM-03 298 294.1 6.4 202 +0.6 235 353 AcceptableCHM-04 245 241.0 5.4 203 +0.7 192 290 AcceptableCHM-05 193 189.2 4.3 202 +0.9 151 228 Acceptable
Lactate DehydrogenaseU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
C-A 2008C-C 2007
C-B 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 6 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 117 122.3 13.9 3145 -0.4 [26]CHM-02 123 130.1 15.0 3146 -0.5 [26]CHM-03 100 107.6 11.7 3151 -0.6 [26]CHM-04 89 92.9 9.5 3145 -0.4 [26]CHM-05 73 77.9 7.7 3150 -0.6 [26]
TestUnit of Measure
Peer Group
LDL Cholesterol, calcmg/dL
CHOL - HDL - (TRIG/5)
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
CHM-01 117 117.0 2.9 101 0.0 81 153 AcceptableCHM-02 124 124.4 3.2 100 -0.1 87 162 AcceptableCHM-03 103 104.5 2.7 103 -0.6 73 136 AcceptableCHM-04 92 91.5 2.3 101 +0.2 64 119 AcceptableCHM-05 78 78.8 1.9 101 -0.4 55 103 Acceptable
LDL, measuredmg/dL
ABBOTT ULTRA LDLC-A 2008
C-B 2007
CHM-01 [11]CHM-02 [11]CHM-03 [11]CHM-04 [11]CHM-05 [11]
Lipoprotein(a)
C-B 2007
x: Result is outside the acceptable limits
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 7 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 1CHM-02 1CHM-03 1CHM-04 1CHM-05 1CHM-01 4.3 3.92 0.19 741 +2.0 2.9 4.9 AcceptableCHM-02 4.6 4.23 0.19 732 +1.9 3.1 5.3 AcceptableCHM-03 3.6 3.32 0.16 737 +1.7 2.4 4.2 AcceptableCHM-04 2.7 2.71 0.13 730 -0.1 2.0 3.4 AcceptableCHM-05 2.2 2.11 0.12 738 +0.8 1.5 2.7 Acceptable
TestUnit of Measure
Peer Group
Magnesiummg/dL
ABBOTT ARCH C/AEROSETCOLOR-DYE-XYLIDYL MAGO
Method Mean
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2008C-C 2007
C-B 2007
CHM-01 6.8 7.01 0.08 217 -2.6 6.5 7.6 AcceptableCHM-02 7.3 7.56 0.08 216 -3.2 7.0 8.1 AcceptableCHM-03 5.6 5.95 0.08 215 -4.3 5.4 6.5 AcceptableCHM-04 4.7 4.91 0.07 216 -3.0 4.4 5.5 AcceptableCHM-05 3.7 3.91 0.06 213 -3.4 3.4 4.5 Acceptable
Potassium, serummmol/L
ABBOTT ARCH C/AEROSETION SELECT ELECT DIL
C-A 2008C-C 2007
C-B 2007
CHM-01 6.7 6.69 0.08 214 +0.2 6.0 7.4 AcceptableCHM-02 7.0 7.00 0.08 213 +0.1 6.2 7.7 AcceptableCHM-03 6.1 6.09 0.07 215 +0.2 5.4 6.7 AcceptableCHM-04 5.5 5.50 0.05 212 0.0 4.9 6.1 AcceptableCHM-05 4.9 4.91 0.05 212 -0.1 4.4 5.4 Acceptable
Protein, total, serumg/dL
ABBOTT ARCH C/AEROSETBIURET
C-A 2008C-C 2007
C-B 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 8 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 155 154.1 1.1 217 +0.8 150 159 AcceptableCHM-02 158 158.4 1.3 219 -0.3 154 163 AcceptableCHM-03 144 145.1 1.1 219 -0.9 141 150 AcceptableCHM-04 138 136.2 1.1 217 +1.7 132 141 AcceptableCHM-05 129 127.7 1.1 219 +1.1 123 132 Acceptable
TestUnit of Measure
Peer Group
Sodium, serummmol/L
ABBOTT ARCH C/AEROSETION SELECT ELECT DIL
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2008C-C 2007
C-B 2007
CHM-01 190 191.1 2.7 38 -0.4 143 239 AcceptableCHM-02 199 201.3 2.8 38 -0.8 150 252 AcceptableCHM-03 170 171.7 2.8 37 -0.6 128 215 AcceptableCHM-04 151 150.5 2.5 37 +0.2 112 189 AcceptableCHM-05 130 129.3 1.9 36 +0.3 97 162 Acceptable
Triglyceridesmg/dL
ABBOTT ARCH C/AEROSETENZ GPO w/o GB w/SB
C-A 2008C-C 2007
C-B 2007
CHM-01 68 65.9 1.4 213 +1.6 59 72 AcceptableCHM-02 75 71.7 1.5 215 +2.2 65 79 AcceptableCHM-03 57 54.2 1.3 219 +2.1 49 60 AcceptableCHM-04 45 42.8 0.9 216 +2.3 38 47 AcceptableCHM-05 32 31.6 0.7 215 +0.6 28 35 Acceptable
Urea, serummg N/dL
ABBOTT ARCH C/AEROSETUREASE WITH GLDH
C-A 2008C-C 2007
C-B 2007
CHM-01 9.2 8.90 0.19 208 +1.6 7.3 10.5 AcceptableCHM-02 9.9 9.57 0.18 207 +1.8 7.9 11.2 AcceptableCHM-03 7.8 7.59 0.18 208 +1.2 6.3 8.9 AcceptableCHM-04 6.5 6.29 0.18 208 +1.2 5.2 7.4 AcceptableCHM-05 5.2 5.01 0.17 208 +1.1 4.1 5.9 Acceptable
Uric Acidmg/dL
ABBOTT ARCH C/AEROSETURICASE
C-A 2008C-C 2007
C-B 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 9 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 191 203.1 8.6 43 -1.4 177 229 AcceptableCHM-02 204 211.3 7.7 42 -1.0 188 235 AcceptableCHM-03 165 179.6 8.4 44 -1.7 154 205 AcceptableCHM-04 143 154.1 6.6 43 -1.7 134 174 AcceptableCHM-05 117 122.3 6.8 44 -0.8 101 143 Acceptable
TestUnit of Measure
Peer Group
Triiodothyronine (T3)ng/dL
ABBOTT ARCHITECT i
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2008C-C 2007
C-B 2007
CHM-01 6.5 6.51 0.27 32 0.0 5.7 7.4 AcceptableCHM-02 6.6 6.96 0.38 33 -1.0 5.8 8.1 AcceptableCHM-03 5.7 5.73 0.33 33 -0.1 4.7 6.8 AcceptableCHM-04 4.9 4.79 0.25 33 +0.4 4.0 5.6 AcceptableCHM-05 4.0 3.72 0.28 33 +1.0 2.8 4.6 Acceptable
T3, freepg/mL
ABBOTT ARCHITECT iC-A 2008C-C 2007
C-B 2007
CHM-01 3.0 3.09 0.27 108 -0.3 2.2 4.0 AcceptableCHM-02 3.3 3.32 0.25 107 -0.1 2.5 4.1 AcceptableCHM-03 2.7 2.71 0.16 108 -0.1 2.2 3.2 AcceptableCHM-04 2.2 2.25 0.15 109 -0.3 1.7 2.8 AcceptableCHM-05 1.9 1.78 0.12 107 +1.0 1.4 2.2 Acceptable
Thyroxine, freeng/dL
ABBOTT ARCHITECT iC-A 2008C-C 2007
C-B 2007
CHM-01 16.1 15.94 1.34 69 +0.1 12.7 19.2 AcceptableCHM-02 17.0 17.12 1.43 69 -0.1 13.6 20.6 AcceptableCHM-03 12.7 13.47 1.03 69 -0.7 10.7 16.2 AcceptableCHM-04 11.4 11.09 0.90 69 +0.3 8.8 13.4 AcceptableCHM-05 8.6 8.68 0.62 69 -0.1 6.9 10.5 Acceptable
Thyroxineug/dL
ABBOTT ARCHITECT iC-A 2008C-C 2007
C-B 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 10 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 9.06 9.960 0.392 125 -2.3 8.78 11.14 AcceptableCHM-02 9.92 10.906 0.421 124 -2.3 9.64 12.17 AcceptableCHM-03 7.26 7.989 0.298 125 -2.4 7.09 8.89 AcceptableCHM-04 5.50 6.075 0.228 123 -2.5 5.39 6.76 AcceptableCHM-05 3.97 4.101 0.146 123 -0.9 3.66 4.55 Acceptable
TestUnit of Measure
Peer Group
Thyroid Stim HormoneuU/mL
ABBOTT ARCHITECT i
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2008C-C 2007
C-B 2007
CHM-01 164 158.9 24.0 131 +0.2 [26]CHM-02 164 171.3 24.5 131 -0.3 [26]
Ammoniaumol/L
ABBOTT ARCH C/AEROSETGLUTAMATE DEHYDROGENA
CHM-01 [11]CHM-02 [11]
Apolipoprotein A1mg/dL
BECKMAN ARRAY
CHM-01 [11]CHM-02 [11]
Apolipoprotein Bmg/dL
BECKMAN ARRAY
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 11 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 4CHM-02 4
CHM-01 1.25 1.310 0.201 698 -0.3 0.70 1.92 AcceptableCHM-02 1.27 1.331 0.205 698 -0.3 0.71 1.95 Acceptable
TestUnit of Measure
Peer Group
Calcium, ionizedmmol/L
OTHER ISE UNDILUTEDOTHER
All Method Principles
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2008C-C 2007C-B 2007
CHM-01 24 24.7 1.2 215 -0.6 20 29 AcceptableCHM-02 30 26.0 1.2 212 +3.5 22 30 Acceptable
CO2mmol/L
ABBOTT ARCH C/AEROSETENZYMATIC
C-A 2008C-C 2007C-B 2007
x: Result is outside the acceptable limits
CHM-01 217 210.3 8.7 56 +0.8 184 237 AcceptableCHM-02 238 225.2 11.5 56 +1.1 190 260 Acceptable
Ferritinng/mL
ABBOTT ARCHITECT iC-A 2008C-C 2007C-B 2007
CHM-01 135 131.6 4.0 181 +0.8 119 144 AcceptableCHM-02 146 143.4 4.4 181 +0.6 130 157 Acceptable
Gamma Glutamyl TransU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
C-A 2008C-C 2007C-B 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 12 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 3CHM-02 3
CHM-01 5.0 5.47 0.42 2313 -1.1 4.1 6.8 AcceptableCHM-02 5.5 5.91 0.45 2315 -0.9 4.5 7.3 Acceptable
TestUnit of Measure
Peer Group
Lactatemmol/L
OTHER ISE UNDILUTEDOTHER
All Method Principles
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2008C-C 2007C-B 2007
CHM-01 6.4 6.59 0.11 215 -1.7 5.8 7.3 AcceptableCHM-02 6.9 7.13 0.12 213 -2.0 6.3 7.9 Acceptable
Phosphorus, serummg/dL
ABBOTT ARCH C/AEROSETPHOSPHOMOLYBDATE UV
C-A 2008C-C 2007C-B 2007
CHM-01 31.19 2.51 10 [11]CHM-02 32.50 2.20 10 [11]
Prealbuminmg/dL
BECKMAN ARRAYC-C 2007C-B 2007
CHM-01 362 353.8 14.6 28 +0.6 283 425 AcceptableCHM-02 356 371.0 11.4 29 -1.3 296 446 AcceptableCHM-03 314 319.4 14.2 29 -0.4 255 384 AcceptableCHM-04 271 285.0 12.3 29 -1.1 228 342 AcceptableCHM-05 249 251.3 13.1 29 -0.2 201 302 Acceptable
Iron Binding Cap, tot.ug/dL
ABBOTT ARCH C/AEROSETALUMINA ADSORPTION
C-A 2008C-C 2007
C-B 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 13 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 58 66.3 16.4 1233 -0.5 [26]CHM-02 63 68.7 18.7 1227 -0.3 [26]CHM-03 56 60.3 11.1 1231 -0.4 [26]CHM-04 54 54.1 7.3 1234 0.0 [26]CHM-05 46 46.7 4.3 1232 -0.2 [26]
TestUnit of Measure
Peer Group
Iron Saturation %%
CALC FROM DIRECT TIBC
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
CHM-01 272 263.4 5.5 51 +1.6 210 317 AcceptableCHM-02 284 275.5 5.6 51 +1.5 220 331 AcceptableCHM-03 248 240.7 5.2 51 +1.4 192 289 AcceptableCHM-04 224 218.2 4.1 50 +1.4 174 262 AcceptableCHM-05 198 195.7 3.8 49 +0.6 156 235 Acceptable
Transferrinmg/dL
ABBOTT ARCH C/AEROSETC-A 2008C-C 2007
C-B 2007
CHM-01 11.0 12.03 0.59 256 -1.7 9.0 15.1 AcceptableCHM-02 12.8 13.01 0.57 253 -0.4 9.7 16.3 AcceptableCHM-03 9.9 10.30 0.56 257 -0.7 7.7 12.9 AcceptableCHM-04 8.5 8.46 0.41 255 +0.1 6.3 10.6 AcceptableCHM-05 6.3 6.72 0.31 256 -1.4 5.0 8.5 Acceptable
Carbamazepineug/mL
ABBOTT AXSYMFPIA
C-A 2008C-C 2007
C-B 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 14 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01CHM-02CHM-03CHM-04CHM-05CHM-01 2.7 2.87 0.21 17 -0.8 2.2 3.5 AcceptableCHM-02 2.7 3.10 0.30 17 -1.3 2.4 3.8 AcceptableCHM-03 2.2 2.40 0.25 17 -0.8 1.9 2.9 AcceptableCHM-04 1.7 1.81 0.20 17 -0.5 1.4 2.2 AcceptableCHM-05 1.3 1.25 0.11 16 +0.5 1.0 1.5 Acceptable
TestUnit of Measure
Peer Group
Digoxinng/mL
ABBOTT AXSYMFPIA
Method/Instrument
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2008
CHM-01 7.8 7.87 0.48 228 -0.1 5.9 9.9 AcceptableCHM-02 8.4 8.55 0.53 227 -0.3 6.4 10.7 AcceptableCHM-03 6.3 6.70 0.40 228 -1.0 5.0 8.4 AcceptableCHM-04 5.4 5.39 0.27 227 +0.1 4.0 6.8 AcceptableCHM-05 3.9 3.97 0.21 225 -0.3 2.9 5.0 Acceptable
Gentamicinug/mL
ABBOTT AXSYMFPIA
C-A 2008C-C 2007
C-B 2007
CHM-01 55.6 51.99 3.43 260 +1.1 41.5 62.4 AcceptableCHM-02 60.8 57.14 4.30 258 +0.9 45.7 68.6 AcceptableCHM-03 44.7 43.26 2.75 257 +0.5 34.6 52.0 AcceptableCHM-04 31.9 33.99 2.02 257 -1.0 27.1 40.8 AcceptableCHM-05 24.7 25.00 1.27 255 -0.2 20.0 30.1 Acceptable
Phenobarbitalug/mL
ABBOTT AXSYMFPIA
C-A 2008C-C 2007
C-B 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 15 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 17.1 17.09 0.55 259 0.0 12.8 21.4 AcceptableCHM-02 18.0 18.37 0.53 255 -0.7 13.7 23.0 AcceptableCHM-03 14.1 14.48 0.42 260 -0.9 10.8 18.1 AcceptableCHM-04 12.4 11.89 0.37 258 +1.4 8.9 14.9 AcceptableCHM-05 9.3 9.23 0.31 259 +0.2 6.9 11.6 Acceptable
TestUnit of Measure
Peer Group
Phenytoinug/mL
ABBOTT AXSYMFPIA
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2008C-C 2007
CHM-01 23.1 23.21 0.91 218 -0.1 17.4 29.1 AcceptableCHM-02 25.7 25.42 1.02 217 +0.3 19.0 31.8 AcceptableCHM-03 19.2 19.30 0.71 219 -0.1 14.4 24.2 AcceptableCHM-04 15.6 15.27 0.59 220 +0.6 11.4 19.1 AcceptableCHM-05 11.2 11.31 0.44 220 -0.2 8.4 14.2 Acceptable
Theophyllineug/mL
ABBOTT AXSYMFPIA
C-A 2008C-C 2007
C-B 2007
CHM-01 86.7 86.16 3.75 271 +0.1 64.6 107.8 AcceptableCHM-02 96.8 93.79 4.23 270 +0.7 70.3 117.3 AcceptableCHM-03 71.1 72.60 3.08 269 -0.5 54.4 90.8 AcceptableCHM-04 58.6 58.30 2.44 269 +0.1 43.7 72.9 AcceptableCHM-05 43.6 44.53 2.24 271 -0.4 33.3 55.7 Acceptable
Valproic Acidug/mL
ABBOTT AXSYMFPIA
C-A 2008C-C 2007
C-B 2007
CHM-01 36.88 36.198 1.849 256 +0.4 30.65 41.75 AcceptableCHM-02 37.83 39.739 2.064 255 -0.9 33.54 45.94 AcceptableCHM-03 31.14 29.890 1.572 256 +0.8 25.17 34.61 AcceptableCHM-04 23.32 23.212 1.160 256 +0.1 19.73 26.70 AcceptableCHM-05 17.29 16.709 0.937 257 +0.6 13.89 19.52 Acceptable
Vancomycinug/mL
ABBOTT AXSYMFPIA
C-A 2008C-C 2007
C-B 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 16 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 23.8 21.29 0.89 237 +2.8 18.6 24.0 AcceptableCHM-02 24.8 23.19 1.02 237 +1.6 20.1 26.3 Acceptable
TestUnit of Measure
Peer Group
Amikacinug/mL
ABBOTT TDx/TDxFLxFPIA
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2008C-C 2007C-B 2007
x: Result is outside the acceptable limits
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 17 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Subspecialty :7181660 Routine ChemistryProficiency Event
2007 2
Regulated Analyte Test Event Score %
Proficiency Event2007 3
Proficiency Event2008 1 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
Satisfactory100C-B 100C-A100C-CALT Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CAlbumin Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CAlkaline Phosphatase Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CAmylase Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CAST Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CBilirubin, Total Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CCalcium, Total Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CChloride Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CCholesterol, Total Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CCholesterol, HDL Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CCreatine Kinase Successful/ / /555 5 5 5Satisfactory100CAR-B 100CAR-A100CAR-CCK Isoenzymes Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CCreatinine Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CGlucose Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CIron, Total Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CLD Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CMagnesium Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CPotassium Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CSodium Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CTotal Protein Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CTriglycerides Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CUrea Nitrogen Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CUric Acid Successful/ / /555 5 5 5
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 18 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Subspecialty :7181660 Routine ChemistryProficiency Event
2007 2
Regulated Analyte Test Event Score %
Proficiency Event2007 3
Proficiency Event2008 1 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
Routine Chemistry 115/115 100 115/115 100 115/115 Satisfactory Successful100
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 19 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
Subspecialty :7181660 ToxicologyProficiency Event
2007 2
Regulated Analyte Test Event Score %
Proficiency Event2007 3
Proficiency Event2008 1 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
Satisfactory100C-B 100C-A100C-CCarbamazepine Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CDigoxin Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CGentamicin Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CPhenobarbital Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CPhenytoin Successful/ / /555 5 5 5 100C-BPrimidone Successful/55Satisfactory100C-B 100C-A100C-CTheophylline Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CValproic Acid Successful/ / /555 5 5 5
Toxicology 40/40 100 35/35 100 35/35 Satisfactory Successful100
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 20 of 20
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176303/3/20084/11/2008
C-A 2008 ChemistryE V A L U A T I O NORIGINAL
EVALUATIONORIGINAL
C-B 2008 Chemistry
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:7/11/20086/2/2008Original Evaluation:
Kit#7181660-01 1
Kit Mailed:20617660 Kit ID:
Claudia Velasquez MT
Next Mailing Date:10/6/2008
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:[11] = Unable to analyze (documentation to be provided by laboratory).[20] = No appropriate target/response cannot be graded.[26] = Educational challenge.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 18
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 128 127.3 3.6 231 +0.2 101 153 AcceptableCHM-07 17 16.5 1.3 229 +0.3 13 20 AcceptableCHM-08 96 95.6 2.6 229 +0.2 76 115 AcceptableCHM-09 33 32.8 1.5 229 +0.1 26 40 AcceptableCHM-10 177 175.4 4.6 230 +0.4 140 211 Acceptable
TestUnit of Measure
Peer Group
ALT (SGPT)U/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2008C-A 2008
C-C 2007
CHM-06 4.1 4.31 0.07 107 -3.0 3.8 4.8 AcceptableCHM-07 2.8 2.90 0.07 111 -1.4 2.6 3.2 AcceptableCHM-08 3.8 3.91 0.08 111 -1.4 3.5 4.3 AcceptableCHM-09 3.0 3.11 0.08 111 -1.5 2.8 3.5 AcceptableCHM-10 4.7 4.88 0.08 112 -2.1 4.3 5.4 Acceptable
Albuming/dL
ABBOTT ARCH C/AEROSETDYE BINDING-BCG
C-B 2008C-A 2008
C-C 2007
CHM-06 245 273.8 4.9 225 -5.9 191 356 AcceptableCHM-07 37 35.4 1.8 223 +0.9 24 46 AcceptableCHM-08 185 205.8 3.8 225 -5.5 144 268 AcceptableCHM-09 68 70.5 2.1 224 -1.2 49 92 AcceptableCHM-10 336 377.5 6.0 222 -6.9 264 491 Acceptable
Alkaline PhosphataseU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
C-B 2008C-A 2008
C-C 2007
CHM-06 254 238.6 5.7 214 +2.7 167 311 AcceptableCHM-07 48 45.0 1.3 213 +2.3 31 59 AcceptableCHM-08 196 183.0 4.4 212 +2.9 128 238 AcceptableCHM-09 78 72.9 1.9 214 +2.7 50 95 AcceptableCHM-10 346 324.8 7.9 213 +2.7 227 423 Acceptable
Amylase, serumU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
C-B 2008C-A 2008
C-C 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 18
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176606/2/20087/11/2008
C-B 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 159 163.7 4.5 226 -1.1 130 197 AcceptableCHM-07 33 35.5 0.9 228 -2.6 28 43 AcceptableCHM-08 123 127.5 3.5 228 -1.3 102 154 AcceptableCHM-09 53 55.3 1.3 228 -1.8 44 67 AcceptableCHM-10 211 218.1 6.1 227 -1.2 174 262 Acceptable
TestUnit of Measure
Peer Group
AST (SGOT)U/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2008C-A 2008
C-C 2007
CHM-06 2.5 2.59 0.15 17 -0.6 2.0 3.2 AcceptableCHM-07 0.4 0.31 0.05 16 +1.8 0.0 0.8 AcceptableCHM-08 2.0 1.97 0.11 17 +0.3 1.5 2.4 AcceptableCHM-09 0.7 0.66 0.06 17 +0.7 0.2 1.1 AcceptableCHM-10 3.2 3.39 0.22 17 -0.9 2.7 4.1 Acceptable
Bilirubin, directmg/dL
ABBOTT ARCH C/AEROSETOXIDATION
C-B 2008C-A 2008
C-C 2007
CHM-06 5.8 5.08 0.37 25 +2.0 4.0 6.1 AcceptableCHM-07 0.7 0.57 0.06 25 +2.1 0.1 1.0 AcceptableCHM-08 4.4 3.79 0.29 25 +2.1 3.0 4.6 AcceptableCHM-09 1.5 1.24 0.10 25 +2.5 0.8 1.7 AcceptableCHM-10 8.0 7.04 0.52 25 +1.9 5.6 8.5 Acceptable
Bilirubin, totalmg/dL
ABBOTT ARCH C/AEROSETOXIDATION
C-B 2008C-A 2008
C-C 2007
CHM-06 10.5 10.97 0.16 234 -2.9 9.9 12.0 AcceptableCHM-07 5.0 5.79 0.09 226 -9.2 4.7 6.8 AcceptableCHM-08 9.0 9.44 0.13 231 -3.5 8.4 10.5 AcceptableCHM-09 5.9 6.55 0.10 231 -6.7 5.5 7.6 AcceptableCHM-10 12.8 13.22 0.16 232 -2.6 12.2 14.3 Acceptable
Calcium, serummg/dL
ABBOTT ARCH C/AEROSETARSENAZO III DYE
C-B 2008C-A 2008
C-C 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 18
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176606/2/20087/11/2008
C-B 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 107 107.0 1.1 237 0.0 101 113 AcceptableCHM-07 79 79.4 1.0 236 -0.4 75 84 AcceptableCHM-08 99 99.0 1.2 237 0.0 94 104 AcceptableCHM-09 83 83.3 1.0 237 -0.3 79 88 AcceptableCHM-10 119 119.4 1.1 233 -0.3 113 126 Acceptable
TestUnit of Measure
Peer Group
Chloridemmol/L
ABBOTT ARCH C/AEROSETION SELECT ELECT DIL
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2008C-A 2008
C-C 2007
CHM-06 226 226.2 2.8 233 -0.1 203 249 AcceptableCHM-07 109 109.0 1.5 233 0.0 98 120 AcceptableCHM-08 192 192.5 2.4 232 -0.2 173 212 AcceptableCHM-09 125 126.0 1.4 231 -0.7 113 139 AcceptableCHM-10 277 277.7 3.7 230 -0.2 249 306 Acceptable
Cholesterolmg/dL
ABBOTT ARCH C/AEROSETENZYMATIC
C-B 2008C-A 2008
C-C 2007
CHM-06 26.4 26.04 1.85 31 +0.2 19.5 32.6 AcceptableCHM-07 4.3 6.28 0.75 31 -2.6 4.7 7.9 UnacceptableCHM-08 18.9 20.40 1.34 31 -1.1 15.2 25.5 AcceptableCHM-09 8.2 9.36 0.95 31 -1.2 7.0 11.8 AcceptableCHM-10 34.5 34.71 2.62 31 -0.1 26.0 43.4 Acceptable
Cortisol, serumug/dL
ABBOTT AXSYMC-B 2008C-A 2008
C-C 2007
x: Result is outside the acceptable limits
CHM-06 553 1 [20]CHM-07 105 1 [20]CHM-08 410 1 [20]CHM-09 176 1 [20]CHM-10 756 1 [20]
Creatine KinaseU/L
OTHER REAGENT/TEMPABBOTT ARCH C/AEROSET
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 4 of 18
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176606/2/20087/11/2008
C-B 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 8CHM-07 8CHM-08 8CHM-09 8CHM-10 8CHM-06 4.58 4.958 0.204 120 -1.9 4.21 5.71 AcceptableCHM-07 0.82 0.844 0.077 121 -0.3 0.54 1.15 AcceptableCHM-08 3.42 3.810 0.151 121 -2.6 3.23 4.39 AcceptableCHM-09 1.35 1.471 0.079 122 -1.5 1.17 1.78 AcceptableCHM-10 6.12 6.725 0.342 122 -1.8 5.71 7.74 Acceptable
TestUnit of Measure
Peer Group
Creatinine, serummg/dL
ALK PICRATE w/o LLOYDSABBOTT ARCH C/AEROSET
TRADITIONAL CALIBRATIO
Cal Method Mean
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2008C-A 2008
C-C 2007
CHM-06 281 277.0 4.3 229 +0.9 249 305 AcceptableCHM-07 61 60.0 1.0 227 +1.1 53 66 AcceptableCHM-08 216 214.0 3.4 232 +0.6 192 236 AcceptableCHM-09 92 92.4 1.6 229 -0.2 83 102 AcceptableCHM-10 378 375.6 6.1 230 +0.4 338 414 Acceptable
Glucose, serummg/dL
ABBOTT ARCH C/AEROSETHEXOKINASE, UV
C-B 2008C-A 2008
C-C 2007
CHM-06 84 82.2 2.8 193 +0.6 57 107 AcceptableCHM-07 38 34.4 2.2 194 +1.6 24 45 AcceptableCHM-08 70 68.0 2.7 195 +0.7 47 89 AcceptableCHM-09 45 41.3 2.3 195 +1.6 28 54 AcceptableCHM-10 105 103.1 3.8 195 +0.5 72 135 Acceptable
HDL Cholesterolmg/dL
ABBOTT ARCH C/AEROSETABBOTT ULTRA HDL
C-B 2008C-A 2008
C-C 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 5 of 18
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176606/2/20087/11/2008
C-B 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06CHM-07CHM-08CHM-09CHM-10CHM-06 658.6 628.65 21.29 116 +1.4 564.7 692.6 AcceptableCHM-07 7.8 8.16 0.84 117 -0.4 5.6 10.7 AcceptableCHM-08 459.4 445.01 16.07 116 +0.9 396.7 493.3 AcceptableCHM-09 102.3 95.27 6.26 118 +1.1 76.4 114.1 AcceptableCHM-10 900.4 868.22 32.67 117 +1.0 770.2 966.3 Acceptable
TestUnit of Measure
Peer Group
hCG, serum, quantmIU/mL
ABBOTT ARCHITECT i
Method
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2008C-A 2008
C-C 2007
CHM-06 173 178.4 4.9 13 -1.1 142 215 AcceptableCHM-07 67 72.6 3.5 13 -1.6 58 88 AcceptableCHM-08 142 148.1 4.4 13 -1.4 118 178 AcceptableCHM-09 82 87.8 3.7 13 -1.5 70 106 AcceptableCHM-10 220 224.5 5.7 13 -0.8 179 270 Acceptable
Ironug/dL
ABBOTT ARCH C/AEROSETFERENE w/PPR
C-B 2008C-A 2008
C-C 2007
CHM-06 292 291.8 6.5 215 0.0 233 351 AcceptableCHM-07 106 106.9 3.1 214 -0.3 85 129 AcceptableCHM-08 240 238.1 5.4 213 +0.3 190 286 AcceptableCHM-09 133 133.4 3.4 213 -0.1 106 161 AcceptableCHM-10 376 372.5 8.5 215 +0.4 297 447 Acceptable
Lactate DehydrogenaseU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
C-B 2008C-A 2008
C-C 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 6 of 18
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176606/2/20087/11/2008
C-B 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 107 109.8 11.1 3381 -0.3 [26]CHM-07 52 56.0 5.8 3387 -0.7 [26]CHM-08 91 94.5 8.9 3380 -0.4 [26]CHM-09 58 63.8 6.0 3385 -1.0 [26]CHM-10 131 132.9 13.7 3379 -0.1 [26]
TestUnit of Measure
Peer Group
LDL Cholesterol, calcmg/dL
CHOL - HDL - (TRIG/5)
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
CHM-06 109 105.9 3.4 118 +0.9 74 138 AcceptableCHM-07 60 59.9 1.8 117 +0.1 41 78 AcceptableCHM-08 96 93.2 2.8 116 +1.0 65 122 AcceptableCHM-09 68 66.4 1.9 117 +0.8 46 87 AcceptableCHM-10 127 127.7 3.8 117 -0.2 89 167 Acceptable
LDL, measuredmg/dL
ABBOTT ULTRA LDLC-B 2008C-A 2008
CHM-06 2CHM-07 2CHM-08 2CHM-09 2CHM-10 2CHM-06 3.4 3.31 0.14 812 +0.6 2.4 4.2 AcceptableCHM-07 1.2 1.19 0.08 801 +0.1 0.8 1.5 AcceptableCHM-08 2.7 2.71 0.13 814 -0.1 2.0 3.4 AcceptableCHM-09 1.5 1.51 0.09 815 -0.1 1.1 1.9 AcceptableCHM-10 4.5 4.23 0.18 820 +1.5 3.1 5.3 Acceptable
Magnesiummg/dL
ABBOTT ARCH C/AEROSETCOLOR-DYE-XYLIDYL MAGO
Method Mean
C-B 2008C-A 2008
C-C 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 7 of 18
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176606/2/20087/11/2008
C-B 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 6.0 5.95 0.07 236 +0.7 5.4 6.5 AcceptableCHM-07 2.4 2.46 0.06 238 -0.9 1.9 3.0 AcceptableCHM-08 5.0 4.92 0.07 237 +1.2 4.4 5.5 AcceptableCHM-09 2.9 2.94 0.06 237 -0.6 2.4 3.5 AcceptableCHM-10 7.7 7.55 0.08 238 +1.9 7.0 8.1 Acceptable
TestUnit of Measure
Peer Group
Potassium, serummmol/L
ABBOTT ARCH C/AEROSETION SELECT ELECT DIL
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2008C-A 2008
C-C 2007
CHM-06 6.0 6.09 0.06 232 -1.5 5.4 6.7 AcceptableCHM-07 4.0 4.02 0.05 236 -0.4 3.6 4.5 AcceptableCHM-08 5.4 5.50 0.05 232 -1.9 4.9 6.1 AcceptableCHM-09 4.3 4.33 0.05 235 -0.5 3.8 4.8 AcceptableCHM-10 6.9 6.99 0.08 235 -1.1 6.2 7.7 Acceptable
Protein, total, serumg/dL
ABBOTT ARCH C/AEROSETBIURET
C-B 2008C-A 2008
C-C 2007
CHM-06 144 145.0 1.2 240 -0.8 140 149 AcceptableCHM-07 113 114.2 1.2 240 -1.0 110 119 AcceptableCHM-08 135 135.9 1.2 241 -0.8 131 140 AcceptableCHM-09 118 118.5 1.1 240 -0.4 114 123 AcceptableCHM-10 158 158.3 1.2 240 -0.2 154 163 Acceptable
Sodium, serummmol/L
ABBOTT ARCH C/AEROSETION SELECT ELECT DIL
C-B 2008C-A 2008
C-C 2007
CHM-06 175 172.1 2.7 44 +1.1 129 216 AcceptableCHM-07 96 93.0 2.2 45 +1.4 69 117 AcceptableCHM-08 155 150.7 2.7 45 +1.6 113 189 AcceptableCHM-09 109 104.8 2.6 45 +1.6 78 132 AcceptableCHM-10 205 202.0 3.2 45 +0.9 151 253 Acceptable
Triglyceridesmg/dL
ABBOTT ARCH C/AEROSETENZ GPO w/o GB w/SB
C-B 2008C-A 2008
C-C 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 8 of 18
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176606/2/20087/11/2008
C-B 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 55 53.9 1.2 240 +1.0 49 59 AcceptableCHM-07 15 14.8 0.5 242 +0.5 12 17 AcceptableCHM-08 44 42.5 1.0 239 +1.5 38 47 AcceptableCHM-09 21 20.4 0.6 242 +0.9 18 23 AcceptableCHM-10 73 71.2 1.3 237 +1.3 64 78 Acceptable
TestUnit of Measure
Peer Group
Urea, serummg N/dL
ABBOTT ARCH C/AEROSETUREASE WITH GLDH
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2008C-A 2008
C-C 2007
CHM-06 7.9 7.67 0.22 225 +1.0 6.3 9.0 AcceptableCHM-07 3.3 3.02 0.21 226 +1.3 2.5 3.6 AcceptableCHM-08 6.6 6.37 0.20 224 +1.1 5.2 7.5 AcceptableCHM-09 3.9 3.70 0.20 225 +1.0 3.0 4.4 AcceptableCHM-10 9.9 9.71 0.18 224 +1.1 8.0 11.4 Acceptable
Uric Acidmg/dL
ABBOTT ARCH C/AEROSETURICASE
C-B 2008C-A 2008
C-C 2007
CHM-06 179 183.9 6.8 48 -0.7 163 205 AcceptableCHM-07 48 52.1 5.9 47 -0.7 34 70 AcceptableCHM-08 151 154.9 5.6 47 -0.7 138 172 AcceptableCHM-09 81 81.2 6.0 47 0.0 63 100 AcceptableCHM-10 208 215.2 9.4 48 -0.8 187 244 Acceptable
Triiodothyronine (T3)ng/dL
ABBOTT ARCHITECT iC-B 2008C-A 2008
C-C 2007
CHM-06 5.9 5.96 0.22 58 -0.3 5.2 6.7 AcceptableCHM-07 1.3 1.79 0.25 59 -1.9 1.0 2.6 AcceptableCHM-08 4.7 4.94 0.25 59 -1.0 4.1 5.7 AcceptableCHM-09 2.2 2.67 0.21 59 -2.2 2.0 3.3 AcceptableCHM-10 7.2 7.20 0.27 58 0.0 6.3 8.1 Acceptable
T3, freepg/mL
ABBOTT ARCHITECT iC-B 2008C-A 2008
C-C 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 9 of 18
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176606/2/20087/11/2008
C-B 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 3.1 2.70 0.20 136 +2.0 2.0 3.4 AcceptableCHM-07 1.1 1.06 0.09 136 +0.5 0.7 1.4 AcceptableCHM-08 2.4 2.24 0.16 136 +1.0 1.7 2.8 AcceptableCHM-09 1.4 1.31 0.09 134 +1.0 1.0 1.6 AcceptableCHM-10 3.4 3.32 0.30 135 +0.3 2.4 4.3 Acceptable
TestUnit of Measure
Peer Group
Thyroxine, freeng/dL
ABBOTT ARCHITECT i
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2008C-A 2008
C-C 2007
CHM-06 13.8 13.80 1.16 78 0.0 11.0 16.6 AcceptableCHM-07 5.2 5.34 0.46 77 -0.3 4.2 6.5 AcceptableCHM-08 11.2 11.21 0.79 78 0.0 8.9 13.5 AcceptableCHM-09 6.4 6.51 0.49 77 -0.2 5.2 7.9 AcceptableCHM-10 16.8 17.09 1.41 77 -0.2 13.6 20.6 Acceptable
Thyroxineug/dL
ABBOTT ARCHITECT iC-B 2008C-A 2008
C-C 2007
CHM-06 7.78 8.075 0.371 149 -0.8 6.96 9.19 AcceptableCHM-07 0.98 1.010 0.049 151 -0.6 0.86 1.16 AcceptableCHM-08 6.00 6.140 0.250 148 -0.6 5.38 6.89 AcceptableCHM-09 2.11 2.099 0.092 149 +0.1 1.82 2.38 AcceptableCHM-10 10.86 10.967 0.440 149 -0.2 9.64 12.29 Acceptable
Thyroid Stim HormoneuU/mL
ABBOTT ARCHITECT iC-B 2008C-A 2008
C-C 2007
CHM-06 153 147.0 21.8 141 +0.3 [26]CHM-07 62 60.5 9.1 140 +0.2 [26]
Ammoniaumol/L
ABBOTT ARCH C/AEROSETGLUTAMATE DEHYDROGENA
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 10 of 18
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176606/2/20087/11/2008
C-B 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 [11]CHM-07 [11]
TestUnit of Measure
Peer Group
Apolipoprotein A1mg/dL
BECKMAN ARRAY
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
CHM-06 [11]CHM-07 [11]
Apolipoprotein Bmg/dL
BECKMAN ARRAY
CHM-06 5CHM-07 5
CHM-06 1.19 1.210 0.093 803 -0.2 0.93 1.49 AcceptableCHM-07 0.61 0.679 0.044 799 -1.6 0.54 0.81 Acceptable
Calcium, ionizedmmol/L
OTHER ISE UNDILUTEDOTHER
All Method Principles
C-B 2008C-A 2008C-C 2007
CHM-06 25 22.0 1.2 232 +2.6 18 26 AcceptableCHM-07 14 13.0 0.8 232 +1.2 10 16 Acceptable
CO2mmol/L
ABBOTT ARCH C/AEROSETENZYMATIC
C-B 2008C-A 2008C-C 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 11 of 18
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176606/2/20087/11/2008
C-B 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 186 179.3 9.6 73 +0.7 150 208 AcceptableCHM-07 55 54.1 2.4 72 +0.4 47 62 Acceptable
TestUnit of Measure
Peer Group
Ferritinng/mL
ABBOTT ARCHITECT i
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2008C-A 2008C-C 2007
CHM-06 107 108.7 3.5 190 -0.5 98 120 AcceptableCHM-07 29 29.0 1.1 190 0.0 25 33 Acceptable
Gamma Glutamyl TransU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
C-B 2008C-A 2008C-C 2007
CHM-06 2CHM-07 2
CHM-06 4.4 4.58 0.36 2580 -0.5 3.5 5.7 AcceptableCHM-07 1.4 1.48 0.18 2570 -0.5 0.9 2.1 Acceptable
Lactatemmol/L
OTHER ISE UNDILUTEDOTHER
All Method Principles
C-B 2008C-A 2008C-C 2007
CHM-06 5.8 5.49 0.10 221 +3.1 4.9 6.1 AcceptableCHM-07 2.0 1.90 0.08 221 +1.4 1.5 2.2 Acceptable
Phosphorus, serummg/dL
ABBOTT ARCH C/AEROSETPHOSPHOMOLYBDATE UV
C-B 2008C-A 2008C-C 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 12 of 18
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176606/2/20087/11/2008
C-B 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 9 [11]CHM-07 9 [11]
TestUnit of Measure
Peer Group
Prealbuminmg/dL
BECKMAN ARRAY
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-C 2007
CHM-06 315 321.7 9.1 30 -0.7 257 387 AcceptableCHM-07 191 207.2 9.4 30 -1.7 165 249 AcceptableCHM-08 258 288.9 11.5 29 -2.7 231 347 AcceptableCHM-09 197 223.0 6.6 29 -4.0 178 268 AcceptableCHM-10 326 370.2 12.2 30 -3.6 296 445 Acceptable
Iron Binding Cap, tot.ug/dL
ABBOTT ARCH C/AEROSETALUMINA ADSORPTION
C-B 2008C-A 2008
C-C 2007
CHM-06 55 61.0 11.2 1348 -0.5 [26]CHM-07 35 34.0 2.4 1327 +0.4 [26]CHM-08 55 54.6 7.2 1345 +0.1 [26]CHM-09 42 39.0 2.6 1325 +1.2 [26]CHM-10 67 70.1 19.6 1340 -0.2 [26]
Iron Saturation %%
CALC FROM DIRECT TIBC
CHM-06 242 240.9 4.5 57 +0.2 192 290 AcceptableCHM-07 162 160.7 3.4 57 +0.4 128 193 AcceptableCHM-08 219 217.8 4.3 57 +0.3 174 262 AcceptableCHM-09 174 172.1 3.6 57 +0.5 137 207 AcceptableCHM-10 282 275.5 5.3 57 +1.2 220 331 Acceptable
Transferrinmg/dL
ABBOTT ARCH C/AEROSETC-B 2008C-A 2008
C-C 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 13 of 18
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176606/2/20087/11/2008
C-B 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 9.5 10.23 0.45 246 -1.6 7.6 12.8 AcceptableCHM-07 3.6 3.92 0.17 248 -1.8 2.9 5.0 AcceptableCHM-08 8.4 8.48 0.34 246 -0.2 6.3 10.6 AcceptableCHM-09 4.9 4.87 0.22 246 +0.2 3.6 6.1 AcceptableCHM-10 12.5 13.03 0.68 246 -0.8 9.7 16.3 Acceptable
TestUnit of Measure
Peer Group
Carbamazepineug/mL
ABBOTT AXSYMFPIA
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2008C-A 2008
C-C 2007
CHM-06 2.1 2.33 0.26 18 -0.9 1.8 2.8 AcceptableCHM-07 0.5 0.45 0.07 17 +0.7 0.2 0.7 AcceptableCHM-08 1.5 1.77 0.22 18 -1.2 1.4 2.2 AcceptableCHM-09 0.8 0.69 0.09 17 +1.2 0.4 0.9 AcceptableCHM-10 2.6 2.97 0.31 18 -1.2 2.3 3.6 Acceptable
Digoxinng/mL
ABBOTT AXSYMFPIA
C-B 2008C-A 2008
CHM-06 6.6 6.62 0.36 217 -0.1 4.9 8.3 AcceptableCHM-07 1.7 1.74 0.10 215 -0.4 1.3 2.2 AcceptableCHM-08 5.4 5.33 0.26 216 +0.3 3.9 6.7 AcceptableCHM-09 2.6 2.45 0.14 217 +1.1 1.8 3.1 AcceptableCHM-10 8.9 8.65 0.54 218 +0.5 6.4 10.9 Acceptable
Gentamicinug/mL
ABBOTT AXSYMFPIA
C-B 2008C-A 2008
C-C 2007
CHM-06 47.3 44.46 3.76 243 +0.8 35.5 53.4 AcceptableCHM-07 10.4 10.97 0.87 243 -0.7 8.7 13.2 AcceptableCHM-08 32.4 35.04 2.77 246 -1.0 28.0 42.1 AcceptableCHM-09 16.3 16.21 1.21 244 +0.1 12.9 19.5 AcceptableCHM-10 58.9 59.24 5.68 242 -0.1 47.3 71.1 Acceptable
Phenobarbitalug/mL
ABBOTT AXSYMFPIA
C-B 2008C-A 2008
C-C 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 14 of 18
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176606/2/20087/11/2008
C-B 2008 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 14.6 14.47 0.47 249 +0.3 10.8 18.1 AcceptableCHM-07 5.0 4.91 0.20 249 +0.4 3.6 6.2 AcceptableCHM-08 11.9 11.88 0.37 250 +0.1 8.9 14.9 AcceptableCHM-09 6.5 6.43 0.24 248 +0.3 4.8 8.1 AcceptableCHM-10 19.2 18.47 0.65 247 +1.1 13.8 23.1 Acceptable
TestUnit of Measure
Peer Group
Phenytoinug/mL
ABBOTT AXSYMFPIA
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2008C-A 2008
C-C 2007
CHM-06 19.3 19.19 0.74 204 +0.1 14.3 24.0 AcceptableCHM-07 5.2 5.23 0.21 203 -0.1 3.9 6.6 AcceptableCHM-08 14.8 15.31 0.54 203 -0.9 11.4 19.2 AcceptableCHM-09 7.3 7.32 0.28 204 -0.1 5.4 9.2 AcceptableCHM-10 27.0 25.57 1.04 201 +1.4 19.1 32.0 Acceptable
Theophyllineug/mL
ABBOTT AXSYMFPIA
C-B 2008C-A 2008
C-C 2007
CHM-06 70.6 72.40 3.35 260 -0.5 54.2 90.5 AcceptableCHM-07 22.1 23.22 1.19 259 -0.9 17.4 29.1 AcceptableCHM-08 55.0 59.02 2.62 258 -1.5 44.2 73.8 AcceptableCHM-09 28.0 30.75 1.62 261 -1.7 23.0 38.5 AcceptableCHM-10 92.8 94.15 4.70 258 -0.3 70.6 117.7 Acceptable
Valproic Acidug/mL
ABBOTT AXSYMFPIA
C-B 2008C-A 2008
C-C 2007
CHM-06 29.61 29.756 1.529 247 -0.1 25.16 34.35 AcceptableCHM-07 7.33 6.576 0.559 244 +1.3 4.89 8.26 AcceptableCHM-08 23.55 23.319 1.218 244 +0.2 19.66 26.98 AcceptableCHM-09 10.90 10.060 0.637 244 +1.3 8.14 11.98 AcceptableCHM-10 38.86 39.433 1.884 243 -0.3 33.78 45.09 Acceptable
Vancomycinug/mL
ABBOTT AXSYMFPIA
C-B 2008C-A 2008
C-C 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 15 of 18
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176606/2/20087/11/2008
C-B 2008 ChemistryE V A L U A T I O NORIGINAL
Subspecialty :7181660 Routine ChemistryProficiency Event
2007 3
Regulated Analyte Test Event Score %
Proficiency Event2008 1
Proficiency Event2008 2 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
Satisfactory100C-C 100C-B100C-AALT Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AAlbumin Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AAlkaline Phosphatase Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AAmylase Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AAST Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ABilirubin, Total Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ACalcium, Total Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AChloride Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ACholesterol, Total Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ACholesterol, HDL Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ACreatine Kinase Successful/ / /555 5 5 5Satisfactory100CAR-C 100CAR-B100CAR-ACK Isoenzymes Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ACreatinine Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AGlucose Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AIron, Total Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ALD Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AMagnesium Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-APotassium Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ASodium Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ATotal Protein Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ATriglycerides Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AUrea Nitrogen Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AUric Acid Successful/ / /555 5 5 5
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 16 of 18
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176606/2/20087/11/2008
C-B 2008 ChemistryE V A L U A T I O NORIGINAL
Subspecialty :7181660 Routine ChemistryProficiency Event
2007 3
Regulated Analyte Test Event Score %
Proficiency Event2008 1
Proficiency Event2008 2 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
Routine Chemistry 115/115 100 115/115 100 115/115 Satisfactory Successful100
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 17 of 18
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176606/2/20087/11/2008
C-B 2008 ChemistryE V A L U A T I O NORIGINAL
Subspecialty :7181660 ToxicologyProficiency Event
2007 3
Regulated Analyte Test Event Score %
Proficiency Event2008 1
Proficiency Event2008 2 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
Satisfactory100C-C 100C-B100C-ACarbamazepine Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ADigoxin Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AGentamicin Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-APhenobarbital Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-APhenytoin Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ATheophylline Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AValproic Acid Successful/ / /555 5 5 5
Toxicology 35/35 100 35/35 100 35/35 Satisfactory Successful100
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 18 of 18
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206176606/2/20087/11/2008
C-B 2008 ChemistryE V A L U A T I O NORIGINAL
EVALUATIONORIGINAL
GH2-A 2008 Glycohemoglobin Survey
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:4/30/20084/8/2008Original Evaluation:
Kit#7181660-01 1
Kit Mailed:20616927 Kit ID:
Claudia Velasquez MT
Next Mailing Date:11/11/2008
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:<NONE>
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 2
<A> - Refer to the Participant Summary for peer group data.
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
GH2-01 13.2 13.00 11.4 14.6 Acceptable<A>GH2-02 5.2 5.30 4.6 6.0 AcceptableGH2-03 8.9 8.80 7.7 9.9 Acceptable
TestUnit of Measure
Peer Group
Glycohgb HBA1c%
BIO-RAD D-10
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
GH2-A 2008GH2-B 2007GH2-A 2007
x: Result is outside the acceptable limits
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 2
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206169274/8/20084/30/2008
GH2-A 2008 Glycohemoglobin SurveyE V A L U A T I O NORIGINAL
EVALUATIONORIGINAL
ELP-B 2008 Electrophoresis
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:9/17/20088/11/2008Original Evaluation:
Kit#7181660-01 1
Kit Mailed:20616982 Kit ID:
Claudia Velasquez MT
Next Mailing Date:4/27/2009
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:[11] = Unable to analyze (documentation to be provided by laboratory).[26] = Educational challenge.[28] = Response qualified with a greater than or less than sign; or a response is not applicable.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 5
P = Based on peer group statistics
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
SPE-03 7.6 7.19 0.35 743 +1.2 6.4 8.0 Acceptable
TestUnit of Measure
Peer Group
Protein, Totalg/dL
BIURET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
ELP-B 2008ELP-A 2008ELP-B 2007
Test
Methods
Unit Of Measure--
Albumin Electrophor g/dLHELENA TITAN GEL
Specimen Your Result S.D. Labs Your GradeS.D.ILimits of Acceptability
Lower UpperEvaluation Statistics
Mean
SPE-03 3.6 [26]P 4.01 0.43 11 -1.0Albumin Electrophor %
HELENA TITAN GEL SPE-03 46.8 [26]9Alpha 1 Globulin g/dL
HELENA TITAN GEL SPE-03 0.3 [26]P 0.33 0.06 11 -0.5Alpha 1 Globulin %
HELENA TITAN GEL SPE-03 4.5 [26]9Alpha 2 Globulin g/dL
HELENA TITAN GEL SPE-03 0.9 [26]P 0.82 0.10 11 +0.8Alpha 2 Globulin %
HELENA TITAN GEL SPE-03 11.9 [26]9Beta Globulin g/dL
HELENA TITAN GEL SPE-03 1.2 [26]P 1.05 0.16 11 +0.9Beta Globulin %
HELENA TITAN GEL SPE-03 16.3 [26]9Total Gamma Globulin g/dL
HELENA TITAN GEL SPE-03 1.6 [26]P 1.29 0.20 11 +1.6Total Gamma Globulin %
HELENA TITAN GEL SPE-03 20.5 [26]9Paraprotein Peak g/dL
HELENA TITAN GEL SPE-03 0.0 [26]5
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206169828/11/20089/17/2008
ELP-B 2008 ElectrophoresisE V A L U A T I O NORIGINAL
Test
Methods
Unit Of Measure--
Paraprotein Peak %HELENA TITAN GEL
Specimen Your Result S.D. Labs Your GradeS.D.ILimits of Acceptability
Lower UpperEvaluation Statistics
Mean
SPE-03 0.0 [26]4Test
Method Specimen Your Result Intended Response Your GradeParaprotein ID
SPE-03 [11]
SPE-03 NO ABNORMALITYSPE Pattern Interp NO ABNORMALITY Good
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
SPE-03 1050 1117.9 56.4 140 -1.2 838 1398 Acceptable
TestUnit of Measure
Peer Group
Immunoglobulin Gmg/dL
BECKMAN IMMAGE
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
ELP-B 2008ELP-A 2008ELP-B 2007
SPE-03 218 234.7 10.1 134 -1.7 204 265 AcceptableImmunoglobulin Amg/dL
BECKMAN IMMAGEELP-B 2008ELP-A 2008ELP-B 2007
SPE-03 101 103.0 5.2 138 -0.4 87 119 AcceptableImmunoglobulin Mmg/dL
BECKMAN IMMAGEELP-B 2008ELP-A 2008ELP-B 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206169828/11/20089/17/2008
ELP-B 2008 ElectrophoresisE V A L U A T I O NORIGINAL
P = Based on peer group statistics
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
SPE-04 4.4 4.57 0.18 739 -1.0 4.1 5.1 Acceptable
TestUnit of Measure
Peer Group
Protein, Totalg/dL
BIURET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
ELP-B 2008ELP-A 2008ELP-B 2007
Test
Methods
Unit Of Measure--
Albumin Electrophor g/dLHELENA TITAN GEL
Specimen Your Result S.D. Labs Your GradeS.D.ILimits of Acceptability
Lower UpperEvaluation Statistics
Mean
SPE-04 1.6 [26]P 1.78 0.17 11 -1.1Albumin Electrophor %
HELENA TITAN GEL SPE-04 37.5 [26]9Alpha 1 Globulin g/dL
HELENA TITAN GEL SPE-04 0.1 [26]P 0.10 0.00 11 0.0Alpha 1 Globulin %
HELENA TITAN GEL SPE-04 2.0 [26]9Alpha 2 Globulin g/dL
HELENA TITAN GEL SPE-04 0.2 [26]P 0.22 0.06 11 -0.3Alpha 2 Globulin %
HELENA TITAN GEL SPE-04 5.1 [26]9Beta Globulin g/dL
HELENA TITAN GEL SPE-04 0.4 [26]P 0.76 0.79 11 -0.5Beta Globulin %
HELENA TITAN GEL SPE-04 9.6 [26]8Total Gamma Globulin g/dL
HELENA TITAN GEL SPE-04 2.0 [26]9Total Gamma Globulin %
HELENA TITAN GEL SPE-04 45.9 [26]8Paraprotein Peak g/dL
HELENA TITAN GEL SPE-04 2.0 [26]8
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 4 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206169828/11/20089/17/2008
ELP-B 2008 ElectrophoresisE V A L U A T I O NORIGINAL
Test
Methods
Unit Of Measure--
Paraprotein Peak %HELENA TITAN GEL
Specimen Your Result S.D. Labs Your GradeS.D.ILimits of Acceptability
Lower UpperEvaluation Statistics
Mean
SPE-04 45.9 [26]6Test
Method Specimen Your Result Intended Response Your GradeParaprotein ID
SPE-04 [11]
SPE-04 M-PROTEIN (PARAPROTEIN.)SPE Pattern Interp M-PROTEIN (PARAPROTEIN.) Good
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
SPE-04 51 58.7 3.5 137 -2.2 44 74 Acceptable
TestUnit of Measure
Peer Group
Immunoglobulin Gmg/dL
BECKMAN IMMAGE
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
ELP-B 2008ELP-A 2008ELP-B 2007
SPE-04 3050 2926.9 219.2 136 +0.6 2269 3585 AcceptableImmunoglobulin Amg/dL
BECKMAN IMMAGEELP-B 2008ELP-A 2008ELP-B 2007
SPE-04 <4 4.4 0.7 12 [28]Immunoglobulin Mmg/dL
BECKMAN IMMAGEELP-A 2008ELP-B 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 5 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206169828/11/20089/17/2008
ELP-B 2008 ElectrophoresisE V A L U A T I O NORIGINAL
EVALUATIONORIGINAL
M-A 2008 Cerebrospinal Fluid Chemistry
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:5/8/20084/14/2008Original Evaluation:
Kit#7181660-01 1
Kit Mailed:20617722 Kit ID:
Claudia Velasquez MT
Next Mailing Date:9/8/2008
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:[11] = Unable to analyze (documentation to be provided by laboratory).[20] = No appropriate target/response cannot be graded.[26] = Educational challenge.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 4
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
M-01 44 43.2 0.9 111 +0.9 37 50 AcceptableM-02 101 101.7 2.0 110 -0.4 91 112 AcceptableM-03 45 44.6 1.0 110 +0.4 38 51 Acceptable
TestUnit of Measure
Peer Group
Glucose CSFmg/dL
ABBOTT ARCH C/AEROSETHEXOKINASE, UV
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
M-A 2008M-B 2007M-A 2007
M-01 23M-02 23M-03 23
M-01 10.9 11.19 0.78 27 -0.4 8.8 13.6 AcceptableM-02 1.9 2.02 0.14 27 -0.8 1.5 2.5 AcceptableM-03 12.1 12.41 0.95 27 -0.3 9.5 15.3 Acceptable
Lactatemmol/L
OTHER MULTI ANALYZEROXIDATION (ELECTRODE)
Method Mean
M-A 2008M-B 2007M-A 2007
M-01 4M-02 4M-03 4
M-01 96.2 110.52 11.02 1798 -1.3 88.4 132.7 AcceptableM-02 41.4 57.34 12.04 1800 -1.3 33.2 81.5 AcceptableM-03 102.6 115.46 11.23 1802 -1.1 92.3 138.6 Acceptable
Protein, Total CSFmg/dL
ABBOTT ARCH C/AEROSETPYROGALLOL RED
Method Mean
M-A 2008M-B 2007M-A 2007
M-01 70.80 2.62 75 [11]M-02 31.78 2.79 76 [11]M-03 75.09 3.17 76 [11]
Albumin (CSF)mg/dL
BECKMAN IMMAGEM-B 2007M-A 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 4
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206177224/14/20085/8/2008
M-A 2008 Cerebrospinal Fluid ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
M-01 232 230.3 8.6 52 +0.2 184 277 AcceptableM-02 16 16.0 2.1 50 0.0 9 23 AcceptableM-03 265 261.4 8.9 51 +0.4 209 314 Acceptable
TestUnit of Measure
Peer Group
Lactate DehydrogenaseU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
M-A 2008M-B 2007M-A 2007
M-01 15.31 0.69 104 [11]M-02 5.59 0.28 103 [11]M-03 17.03 0.81 105 [11]
IgG (CSF)mg/dL
BECKMAN IMMAGE M-A 2007
M-01 65 8 [20]M-02 81 8 [20]M-03 53 8 [20]
Albumin Electrophor%
HELENA TITAN GEL
M-01 21 8 [26]M-02 11 8 [26]M-03 32 7 [26]
Gamma Globulin%
HELENA TITAN GEL
TestMethod Specimen Your Result Intended Response Your Grade
Oligoclonal BandsM-01 PRESENTHELENA TITAN GEL SINGLE BAND PRESENT Good
SINGLE BAND PRESENT
M-02 ABSENTABSENT Good
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 4
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206177224/14/20085/8/2008
M-A 2008 Cerebrospinal Fluid ChemistryE V A L U A T I O NORIGINAL
TestMethod Specimen Your Result Intended Response Your Grade
M-03 PRESENTHELENA TITAN GEL PRESENT GoodSINGLE BAND PRESENT
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 4 of 4
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206177224/14/20085/8/2008
M-A 2008 Cerebrospinal Fluid ChemistryE V A L U A T I O NORIGINAL
EVALUATIONORIGINAL
U-A 2008 Urine Chemistry-Genl
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:2/18/20081/7/2008Original Evaluation:
Kit#7181660-01 1
Kit Mailed:20617074 Kit ID:
Claudia Velasquez MT
Next Mailing Date:5/19/2008
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:[11] = Unable to analyze (documentation to be provided by laboratory).[26] = Educational challenge.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 5
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
U-01 26.88 0.57 104 +0.2U-02 12.63 0.21 105 -1.1U-03 13.59 0.18 104 -0.5
U-01 27.0 27.45 1.30 1880 -0.3 18.9 36.0 AcceptableU-02 12.4 12.74 0.51 1902 -0.7 8.7 16.7 AcceptableU-03 13.5 13.60 0.48 1893 -0.2 9.3 17.9 Acceptable
TestUnit of Measure
Peer Group
Calcium, urinemg/dL
ABBOTT ARCH C/AEROSETARSENAZO III DYE
All Methods/All Instruments
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
U-A 2008U-B 2007U-A 2007
U-01 279.8 5.4 70 -0.9U-02 76.6 1.4 71 -0.4U-03 71.4 1.5 70 +0.4
U-01 275 271.1 8.2 1419 +0.5 216 326 AcceptableU-02 76 76.7 2.7 1427 -0.3 61 93 AcceptableU-03 72 71.5 2.6 1425 +0.2 57 86 Acceptable
Glucose, urinemg/dL
ABBOTT ARCH C/AEROSETHEXOKINASE, UV
All Methods/All Instruments
U-A 2008U-B 2007U-A 2007
U-01 1U-02 1U-03 1
U-01 9.3 9.32 0.56 1238 0.0 6.9 11.7 AcceptableU-02 9.1 9.06 0.55 1241 +0.1 6.7 11.4 AcceptableU-03 6.5 6.38 0.68 1247 +0.2 4.7 8.0 Acceptable
Magnesium, urinemg/dL
ABBOTT ARCH C/AEROSETCOLOR-DYE-XYLIDYL MAGO
All Methods/All Instruments
U-A 2008U-B 2007U-A 2007
U-01 2.7 2.44 0.16 97 +1.6 1.7 3.2 AcceptableU-02 96.9 88.41 4.20 92 +2.0 61.8 115.0 AcceptableU-03 2.9 2.63 0.16 97 +1.7 1.8 3.5 Acceptable
Urine albuminmg/dL
ABBOTT ARCH C/AEROSETTURBIDIMETRIC
U-A 2008U-B 2007U-A 2007
x: Result is outside the acceptable limits
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206170741/7/20082/18/2008
U-A 2008 Urine Chemistry-GenlE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
U-01 78.09 10.30 1327 [11]U-02 1783.85 167.82 1218 [11]U-03 54.45 7.45 1332 [11]
TestUnit of Measure
Peer Group
Urine albumin/creat ramg/g
Microalbumin/creatinine ratio
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
U-01U-02U-03
U-01 31 30.1 2.2 2644 +0.4 25 36 AcceptableU-02 51 49.3 3.2 2624 +0.5 40 58 AcceptableU-03 47 46.1 3.0 2632 +0.3 38 54 Acceptable
Creatininemg/dL
ABBOTT ARCH C/AEROSETRATE-BLK KIN ALK PIC
All Methods/All Instruments
U-A 2008U-B 2007U-A 2007
U-01 39.2 1.2 75 -0.2U-02 107.6 3.0 74 -3.5U-03 131.2 3.2 72 -4.8
U-01 39 40.0 2.1 1599 -0.5 30 50 AcceptableU-02 97 108.5 6.3 1580 -1.8 83 134 AcceptableU-03 116 132.4 7.8 1583 -2.1 101 163 Acceptable
Phosphorus, urinemg/dL
ABBOTT ARCH C/AEROSETPHOSPHOMOLYBDATE UV
All Methods/All Instruments
U-A 2008U-B 2007U-A 2007
U-01 45.1 0.6 123 -0.2U-02 53.8 0.7 123 -1.1U-03 119.9 1.8 123 -1.1
U-01 45 45.4 1.8 2573 -0.3 32 59 AcceptableU-02 53 53.4 2.2 2569 -0.2 37 69 AcceptableU-03 118 120.3 6.3 2514 -0.4 85 156 Acceptable
Potassium, urinemmol/L
ABBOTT ARCH C/AEROSETION SELECTIVE ELECTROD
All Methods/All Instruments
U-A 2008U-B 2007U-A 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206170741/7/20082/18/2008
U-A 2008 Urine Chemistry-GenlE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
U-04 36 34.8 0.8 115 +1.4 25 44 AcceptableU-05 40 39.8 0.9 117 +0.2 29 51 AcceptableU-06 36 35.4 0.9 117 +0.7 26 45 Acceptable
TestUnit of Measure
Peer Group
Chloride, urinemmol/L
ABBOTT ARCH C/AEROSETION SELECTIVE ELECTROD
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
U-A 2008U-B 2007U-A 2007
U-04 3U-05 3U-06 3
U-04 67 64.5 3.8 1506 +0.7 53 76 AcceptableU-05 98 94.7 4.7 1510 +0.7 78 111 AcceptableU-06 159 148.4 6.7 1502 +1.6 123 174 Acceptable
Creatinine, urinemg/dL
RATE-BLK KIN ALK PICABBOTT ARCH C/AEROSET
TRADITIONAL CALIBRATIO
Caltype/All Methods/All Instru
U-A 2008U-B 2007U-A 2007
U-04 441 4 [26]U-05 594 4 [26]U-06 730 4 [26]
Nitrogen, totalmg/dL
OTHER
U-04 10.53 0.71 90 +1.1U-05 19.46 0.72 90 +1.0U-06 19.13 0.73 89 +0.8
U-04 11.3 10.87 0.99 1664 +0.4 8.2 13.5 AcceptableU-05 20.2 19.98 1.21 1665 +0.2 15.1 24.8 AcceptableU-06 19.7 19.73 1.24 1668 0.0 14.9 24.5 Acceptable
Uric Acid, urinemg/dL
ABBOTT ARCH C/AEROSETURICASE
All Methods/All Instruments
U-A 2008U-B 2007U-A 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 4 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206170741/7/20082/18/2008
U-A 2008 Urine Chemistry-GenlE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
U-04 58 54.7 1.7 92 +1.9 49 60 AcceptableU-05 229 216.9 5.9 92 +2.0 199 235 AcceptableU-06 294 277.7 7.2 92 +2.3 256 300 Acceptable
TestUnit of Measure
Peer Group
Amylase, urineU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
U-A 2008U-B 2007U-A 2007
U-04 7.2 0.8 89 -0.3U-05 106.2 2.2 122 -0.1U-06 133.1 2.8 122 -0.4
U-04 7 9.8 1.8 2507 -1.6 5 15 AcceptableU-05 106 109.0 7.4 2612 -0.4 61 157 AcceptableU-06 132 134.0 9.1 2563 -0.2 75 194 Acceptable
Protein, Totalmg/dL
ABBOTT ARCH C/AEROSETBENZETHONIUM CHLORIDE
All Methods/All Instruments
U-A 2008U-B 2007U-A 2007
U-04 41.6 1.0 127 -1.6U-05 63.0 1.1 128 -1.8U-06 58.5 1.0 127 -2.5
U-04 40 41.9 1.9 2581 -1.0 30 53 AcceptableU-05 61 65.0 2.2 2576 -1.8 48 82 AcceptableU-06 56 60.2 2.2 2574 -1.9 44 76 Acceptable
Sodium, urinemmol/L
ABBOTT ARCH C/AEROSETION SELECTIVE ELECTROD
All Methods/All Instruments
U-A 2008U-B 2007U-A 2007
TestSpecimen Your GradeAcceptable ResponseMethod Your Result Good Response
Bence Jones Protein
U-97 NO BENCE JONES PROTEIN [26]
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 5 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206170741/7/20082/18/2008
U-A 2008 Urine Chemistry-GenlE V A L U A T I O NORIGINAL
EVALUATIONORIGINAL
U-B 2008 Urine Chemistry-Genl
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:6/25/20085/19/2008Original Evaluation:
Kit#7181660-01 1
Kit Mailed:21377610 Kit ID:
Claudia Velasquez MT
Next Mailing Date:1/5/2009
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:[26] = Educational challenge.[28] = Response qualified with a greater than or less than sign; or a response is not applicable.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 5
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
U-07 68.05 3.18 104 +1.5U-08 25.42 0.49 113 -0.9U-09 57.04 2.63 106 +1.0
U-07 72.7 69.20 5.09 1869 +0.7 47.7 90.7 AcceptableU-08 25.0 26.25 1.22 1931 -1.0 18.1 34.4 AcceptableU-09 59.7 58.50 3.75 1874 +0.3 40.3 76.7 Acceptable
TestUnit of Measure
Peer Group
Calcium, urinemg/dL
ABBOTT ARCH C/AEROSETARSENAZO III DYE
All Methods/All Instruments
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
U-B 2008U-A 2008U-B 2007
U-07 34.9 0.8 71 +0.1U-08 219.3 4.1 70 +0.2U-09 33.5 0.9 70 +0.6
U-07 35 36.3 2.2 1479 -0.6 29 44 AcceptableU-08 220 216.4 6.1 1487 +0.6 173 260 AcceptableU-09 34 35.1 2.5 1480 -0.5 28 43 Acceptable
Glucose, urinemg/dL
ABBOTT ARCH C/AEROSETHEXOKINASE, UV
All Methods/All Instruments
U-B 2008U-A 2008U-B 2007
U-07 1U-08 1U-09 1
U-07 25.0 25.65 1.46 1251 -0.4 19.2 32.1 AcceptableU-08 14.0 13.53 0.68 1264 +0.7 10.1 17.0 AcceptableU-09 20.0 20.74 1.13 1260 -0.7 15.5 26.0 Acceptable
Magnesium, urinemg/dL
ABBOTT ARCH C/AEROSETCOLOR-DYE-XYLIDYL MAGO
All Methods/All Instruments
U-B 2008U-A 2008U-B 2007
U-07 1.2 1.34 0.10 91 -1.4 0.9 1.8 AcceptableU-08 1.0 1.09 0.10 93 -0.9 0.7 1.5 AcceptableU-09 10.2 9.25 0.33 94 +2.9 6.4 12.1 Acceptable
Urine albuminmg/dL
ABBOTT ARCH C/AEROSETTURBIDIMETRIC
U-B 2008U-A 2008U-B 2007
x: Result is outside the acceptable limits
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
213776105/19/20086/25/2008
U-B 2008 Urine Chemistry-GenlE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
U-07U-08U-09
U-07 54 53.8 3.5 2773 +0.1 44 63 AcceptableU-08 162 164.0 8.4 2776 -0.2 136 192 AcceptableU-09 91 91.8 5.4 2771 -0.1 76 108 Acceptable
TestUnit of Measure
Peer Group
Creatininemg/dL
ABBOTT ARCH C/AEROSETRATE-BLK KIN ALK PIC
All Methods/All Instruments
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
U-B 2008U-A 2008U-B 2007
U-07 39.3 1.1 82 +2.5U-08 59.9 1.5 82 +2.1U-09 38.6 1.0 81 +2.4
U-07 42 40.6 2.2 1631 +0.6 31 50 AcceptableU-08 63 62.1 3.3 1632 +0.3 47 77 AcceptableU-09 41 39.9 2.3 1634 +0.5 30 50 Acceptable
Phosphorus, urinemg/dL
ABBOTT ARCH C/AEROSETPHOSPHOMOLYBDATE UV
All Methods/All Instruments
U-B 2008U-A 2008U-B 2007
U-07 33.7 0.6 140 +0.5U-08 100.2 1.3 138 +0.6U-09 122.3 1.6 136 -0.2
U-07 34 33.8 1.0 2689 +0.2 23 44 AcceptableU-08 101 100.4 4.2 2654 +0.2 71 130 AcceptableU-09 122 123.0 5.5 2625 -0.2 87 159 Acceptable
Potassium, urinemmol/L
ABBOTT ARCH C/AEROSETION SELECTIVE ELECTROD
All Methods/All Instruments
U-B 2008U-A 2008U-B 2007
U-10 <20 21.2 1.0 122 [28]U-11 83 81.9 1.0 128 +1.1 60 104 AcceptableU-12 124 123.2 1.4 126 +0.6 91 156 Acceptable
Chloride, urinemmol/L
ABBOTT ARCH C/AEROSETION SELECTIVE ELECTROD
U-B 2008U-A 2008U-B 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
213776105/19/20086/25/2008
U-B 2008 Urine Chemistry-GenlE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
U-10 4U-11 4U-12 4
U-10 59 59.2 3.5 1365 0.0 49 70 AcceptableU-11 96 98.3 5.3 1357 -0.4 81 116 AcceptableU-12 138 140.4 7.0 1360 -0.3 116 165 Acceptable
TestUnit of Measure
Peer Group
Creatinine, urinemg/dL
RATE-BLK KIN ALK PICABBOTT ARCH C/AEROSET
TRADITIONAL CALIBRATIO
Caltype/All Methods/All Instru
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
U-B 2008U-A 2008U-B 2007
U-10 431 3 [26]U-11 592 3 [26]U-12 685 3 [26]
Nitrogen, totalmg/dL
OTHER
U-10 21.95 0.73 94 -0.8U-11 10.96 0.73 95 -0.5U-12 19.87 0.71 94 -0.7
U-10 21.4 22.50 1.35 1710 -0.8 17.0 27.9 AcceptableU-11 10.6 11.46 1.10 1709 -0.8 8.7 14.3 AcceptableU-12 19.4 20.47 1.30 1708 -0.8 15.5 25.4 Acceptable
Uric Acid, urinemg/dL
ABBOTT ARCH C/AEROSETURICASE
All Methods/All Instruments
U-B 2008U-A 2008U-B 2007
U-10 115 108.2 3.0 105 +2.3 99 118 AcceptableU-11 177 167.6 4.6 106 +2.1 153 182 AcceptableU-12 260 242.9 6.6 104 +2.6 223 263 Acceptable
Amylase, urineU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
U-B 2008U-A 2008U-B 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 4 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
213776105/19/20086/25/2008
U-B 2008 Urine Chemistry-GenlE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
U-10 111.3 2.3 122 +1.2U-11 95.8 2.0 122 +1.1U-12 133.3 3.0 122 +0.9
U-10 114 110.9 6.0 2343 +0.5 62 160 AcceptableU-11 98 105.9 9.8 2356 -0.8 59 153 AcceptableU-12 136 132.2 7.3 2349 +0.5 74 191 Acceptable
TestUnit of Measure
Peer Group
Protein, Totalmg/dL
ABBOTT ARCH C/AEROSETBENZETHONIUM CHLORIDE
All Methods/All Instruments
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
U-B 2008U-A 2008U-B 2007
U-10 38.7 0.9 138 -0.8U-11 153.5 2.7 140 +1.3U-12 146.0 2.4 139 +0.8
U-10 38 38.5 1.9 2687 -0.2 28 49 AcceptableU-11 157 154.7 3.4 2690 +0.7 114 195 AcceptableU-12 148 148.6 2.9 2699 -0.2 109 188 Acceptable
Sodium, urinemmol/L
ABBOTT ARCH C/AEROSETION SELECTIVE ELECTROD
All Methods/All Instruments
U-B 2008U-A 2008U-B 2007
TestSpecimen Your GradeAcceptable ResponseMethod Your Result Good Response
Bence Jones Protein
OTHER U-98 NO BENCE JONES PROTEIN [26]
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 5 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
213776105/19/20086/25/2008
U-B 2008 Urine Chemistry-GenlE V A L U A T I O NORIGINAL
Laboratory Results Summary
Page
Print Date
Laboratory CO1033AI Laboratorio Medico Las Americas
2008/Mar/20Test event 1 of 2
11 / 13
Sweat Testing (SWEA423) - Performance ReportCAP LAP Number 7181660
Instrument Nickname: SweatcheckSubscription ID 32225 Cycle: 01 - 2008Instrument Model: Wescor Sweat-Chek
Results Deadline 2008/Mar/11
Analyte SampleYOUR LAB'S DATA
Result Reason
Code
SDI Grade Statistical
Count
Mean
COMPARATIVE GROUP DATA
SD CV(%) Peer Group Code:Description Acceptable Results
» Conductivity mmol/L
A ACC 9 RM:Wescor Inc.133 119 - 1382.9128.4 1.56 2.3
B ACC 9 RM:Wescor Inc.39 32 - 431.737.7 0.77 4.6
C ACC 9 RM:Wescor Inc.72 65 - 741.369.7 1.76 1.9
Analyte Score: 100.00% Percentile: 100.00%
Grade: ACC - Acceptable; UNACC - Unacceptable; *ACC or *UNACC (i.e. grade preceded by an asterisk) indicates ungradable due to lack of (80%) peer group concensus or insufficient peer group.
» This result is designated for regulatory purposes.
Peer Group(PG) Codes: AR-all results; ME-method; SM-submethod; RM-reagent manufacturer; RG-reagent group; RE-reagent; IM-instrument manufacturer; IG-instrument group; ID-instrument model
Reason Codes: 1(Failure to participate (0% score)); 11(below linear/detection limit); 2(Failure - Excl Requested (100% score)); 22(above linear/detection limit); 88(testing suspended during test event);
EVALUATIONORIGINAL
CR-A 2008 Cardiac Risk
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:4/14/20083/24/2008Original Evaluation:
Kit#7181660-01 1
Kit Mailed:20616623 Kit ID:
Claudia Velasquez MT
Next Mailing Date:11/3/2008
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:<NONE>
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 2
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
HMS-01 5.0 5.13 0.34 160 -0.4 4.0 6.2 AcceptableHMS-02 61.3 64.73 4.20 153 -0.8 52.1 77.4 AcceptableHMS-03 12.2 12.16 0.62 162 +0.1 10.2 14.1 Acceptable
HMS-01 3.97 0.89 747 +1.2HMS-02 53.83 9.06 715 +0.8HMS-03 10.72 1.77 764 +0.8
TestUnit of Measure
Peer Group
Homocysteineumol/L
FPIA
All Method
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
CR-A 2008CR-B 2007CR-A 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 2
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206166233/24/20084/14/2008
CR-A 2008 Cardiac RiskE V A L U A T I O NORIGINAL
EVALUATIONORIGINAL
CAR-A 2008 Cardiac Survey Set
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:3/20/20082/26/2008Original Evaluation:
Kit#7181660-01 1
Kit Mailed:20616565 Kit ID:
Claudia Velasquez MT
Next Mailing Date:6/3/2008
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:[20] = No appropriate target/response cannot be graded.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 5
P = Based on peer group statistics
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CR-01 372 1 [20]CR-02 368 1 [20]CR-03 532 1 [20]CR-04 129 1 [20]CR-05 485 1 [20]
TestUnit of Measure
Peer Group
Creatine KinaseU/L
OTHER REAGENT/TEMPABBOTT ARCHITECT i
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
CR-01 34.0 4 [20]CR-05 49.0 4 [20]
CK-MB, quant, U/LU/L
OTHER
Test
Methods
Unit Of Measure--
CK-MB, quant, U/L U/LOTHER
Specimen Your Result S.D. Labs Your GradeS.D.ILimits of Acceptability
Lower UpperEvaluation Statistics
Mean
CR-02 2.0 [20]P 1CR-03 5.0 [20]P 1CR-04 4.0 [20]P 1
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CR-01 528 526.3 12.4 10 +0.1 421 632 AcceptableCR-02 546 549.7 15.6 10 -0.2 439 660 AcceptableCR-03 537 538.3 14.9 10 -0.1 430 646 AcceptableCR-04 166 163.2 4.7 10 +0.6 130 196 AcceptableCR-05 490 492.0 14.2 10 -0.1 393 591 Acceptable
TestUnit of Measure
Peer Group
Lactate DehydrogenaseU/L
ABBOTT/37 CABBOTT ARCHITECT i
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
CAR-A 2008CAR-C 2007
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206165652/26/20083/20/2008
CAR-A 2008 Cardiac Survey SetE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CR-01 10.50 12.268 0.745 114 -2.4 8.00 16.00 AcceptableCR-02 2.52 3.105 0.183 112 -3.2 2.00 5.00 Acceptable
TestUnit of Measure
Peer Group
Troponin I, quantng/mL
ABBOTT ARCHITECT i
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
CAR-A 2008CAR-C 2007CAR-B 2007
x: Result is outside the acceptable limits
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206165652/26/20083/20/2008
CAR-A 2008 Cardiac Survey SetE V A L U A T I O NORIGINAL
Subspecialty :7181660 Routine ChemistryProficiency Event
2007 2
Regulated Analyte Test Event Score %
Proficiency Event2007 3
Proficiency Event2008 1 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
100C-B 100C-CALT Successful/ /55 5 5 100C-B 100C-CAlbumin Successful/ /55 5 5 100C-B 100C-CAlkaline Phosphatase Successful/ /55 5 5 100C-B 100C-CAmylase Successful/ /55 5 5 100C-B 100C-CAST Successful/ /55 5 5 100C-B 100C-CBilirubin, Total Successful/ /55 5 5 100C-B 100C-CCalcium, Total Successful/ /55 5 5 100C-B 100C-CChloride Successful/ /55 5 5 100C-B 100C-CCholesterol, Total Successful/ /55 5 5 100C-B 100C-CCholesterol, HDL Successful/ /55 5 5 100C-B 100C-CCreatine Kinase Successful/ /55 5 5Satisfactory100CAR-B 100CAR-A100CAR-CCK Isoenzymes Successful/ / /555 5 5 5 100C-B 100C-CCreatinine Successful/ /55 5 5 100C-B 100C-CGlucose Successful/ /55 5 5 100C-B 100C-CIron, Total Successful/ /55 5 5 100C-B 100C-CLD Successful/ /55 5 5 100C-B 100C-CMagnesium Successful/ /55 5 5 100C-B 100C-CPotassium Successful/ /55 5 5 100C-B 100C-CSodium Successful/ /55 5 5 100C-B 100C-CTotal Protein Successful/ /55 5 5 100C-B 100C-CTriglycerides Successful/ /55 5 5 100C-B 100C-CUrea Nitrogen Successful/ /55 5 5 100C-B 100C-CUric Acid Successful/ /55 5 5
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 4 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206165652/26/20083/20/2008
CAR-A 2008 Cardiac Survey SetE V A L U A T I O NORIGINAL
Subspecialty :7181660 Routine ChemistryProficiency Event
2007 2
Regulated Analyte Test Event Score %
Proficiency Event2007 3
Proficiency Event2008 1 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
Routine Chemistry 115/115 100 115/115 100 5/5 Satisfactory Successful100
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 5 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
206165652/26/20083/20/2008
CAR-A 2008 Cardiac Survey SetE V A L U A T I O NORIGINAL